These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8602055)

  • 1. Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old.
    Pahor M; Guralnik JM; Furberg CD; Carbonin P; Havlik R
    Lancet; 1996 Apr; 347(9008):1061-5. PubMed ID: 8602055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of suicide in users of beta-adrenoceptor blockers, calcium channel blockers and angiotensin converting enzyme inhibitors.
    Sørensen HT; Mellemkjaer L; Olsen JH
    Br J Clin Pharmacol; 2001 Sep; 52(3):313-8. PubMed ID: 11560564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of calcium channel blockers and risk of suicide: ecological findings confirmed in population based cohort study.
    Lindberg G; Bingefors K; Ranstam J; Råstam L; Melander A
    BMJ; 1998 Mar; 316(7133):741-5. PubMed ID: 9529409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. African-American ethnicity in epidemiological studies of calcium antagonists in relation to cancer.
    Zhu K; Daling JR; Pahor M
    Ethn Dis; 2002; 12(1):144-8. PubMed ID: 11913603
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk of hospitalized and non-hospitalized gastrointestinal bleeding in ALLHAT trial participants receiving diuretic, ACE-inhibitor, or calcium-channel blocker.
    Du XL; Simpson LM; Tandy BC; Bettencourt JL; Davis BR
    PLoS One; 2021; 16(11):e0260107. PubMed ID: 34793552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of different antihypertensive drugs on pain and joint space width of knee osteoarthritis - A comparative study with data from Osteoarthritis Initiative.
    Li M; Zeng Y; Nie Y; Wu Y; Liu Y; Wu L; Xu J; Shen B
    J Clin Hypertens (Greenwich); 2021 Nov; 23(11):2009-2015. PubMed ID: 34657366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of beta-blockers and risk of serious upper gastrointestinal bleeding: a population-based case-control study.
    Reilev M; Damkier P; Rasmussen L; Olesen M; Thomsen Ernst M; Rishøj RM; Rix Hansen M; Broe A; Dastrup AS; Hellfritzsch M; Arnspang S; Pottegård A; Hallas J
    Therap Adv Gastroenterol; 2017 Dec; 10(12):919-929. PubMed ID: 29204187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal Side Effects of Antiarrhythmic Medications: A Review of Current Literature.
    Amjad W; Qureshi W; Farooq A; Sohail U; Khatoon S; Pervaiz S; Narra P; Hasan SM; Ali F; Ullah A; Guttmann S
    Cureus; 2017 Sep; 9(9):e1646. PubMed ID: 29142794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative safety and effectiveness of cognitive enhancers for Alzheimer's dementia: protocol for a systematic review and individual patient data network meta-analysis.
    Veroniki AA; Straus SE; Ashoor HM; Hamid JS; Hemmelgarn BR; Holroyd-Leduc J; Majumdar SR; McAuley G; Tricco AC
    BMJ Open; 2016 Jan; 6(1):e010251. PubMed ID: 26769792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, prescribing and barriers to effective management of hypertension in older populations: a narrative review.
    Alhawassi TM; Krass I; Pont LG
    J Pharm Policy Pract; 2015; 8():24. PubMed ID: 26473036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium channel blockers and risk of breast cancer: a meta-analysis of 17 observational studies.
    Li W; Shi Q; Wang W; Liu J; Li Q; Hou F
    PLoS One; 2014; 9(9):e105801. PubMed ID: 25184210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of hospitalized gastrointestinal bleeding in persons randomized to diuretic, ACE-inhibitor, or calcium-channel blocker in ALLHAT.
    Phillips W; Piller LB; Williamson JD; Whittle J; Jafri SZ; Ford CE; Einhorn PT; Oparil S; Furberg CD; Grimm RH; Alderman MH; Davis BR; Probstfield JL;
    J Clin Hypertens (Greenwich); 2013 Nov; 15(11):825-32. PubMed ID: 24283598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatoryactivity of calciumchannel blocker lercanidipine hydrochloride.
    Vasigar P; Batmanabane M
    J Pharmacol Pharmacother; 2013 Oct; 4(4):238-42. PubMed ID: 24250199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive medications and anemia.
    Sica DA; Mannino R
    J Clin Hypertens (Greenwich); 2007 Sep; 9(9):723-7. PubMed ID: 17786076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydropyridine calcium channel antagonists in the management of hypertension.
    Epstein BJ; Vogel K; Palmer BF
    Drugs; 2007; 67(9):1309-27. PubMed ID: 17547473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to and strategies for effective blood pressure control.
    Siegel D
    Vasc Health Risk Manag; 2005; 1(1):9-14. PubMed ID: 17319093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of existing and newer calcium channel blockers in the treatment of hypertension.
    Basile J
    J Clin Hypertens (Greenwich); 2004 Nov; 6(11):621-29; quiz 630-1. PubMed ID: 15538095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lacidipine: a review of its use in the management of hypertension.
    McCormack PL; Wagstaff AJ
    Drugs; 2003; 63(21):2327-56. PubMed ID: 14524737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute upper gastrointestinal hemorrhage. Diagnosis and management].
    Nietsch H; Lotterer E; Fleig WE
    Internist (Berl); 2003 May; 44(5):519-28, 530-2. PubMed ID: 12966782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term effects of nisoldipine on the progression of coronary atherosclerosis and the occurrence of clinical events: the NICOLE study.
    Dens JA; Desmet WJ; Coussement P; De Scheerder IK; Kostopoulos K; Kerdsinchai P; Supanantaroek C; Piessens JH
    Heart; 2003 Aug; 89(8):887-92. PubMed ID: 12860866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.